MedOncMD

To provide the information your oncologist is not telling you or doesn't have the time to!

  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts
Breast caner and mental health

Breast Cancer and Mental Health: Navigating the Emotional Journey

A breast cancer diagnosis is a life-altering event that extends its impact far beyond the physical realm. It sends ripples through the emotional and psychological landscape, affecting not only the patient but also their families. In recognition of Breast Cancer Awareness Month, let’s delve into the emotional journey that often accompanies a breast cancer diagnosis …

Read On »

mental health

Mental Health Week

Hello, MedOncMD.com readers! This week is Mental Health Week, and I want to extend a special shoutout to our mental health professionals. In the field of oncology, we recognize the importance of mental health. The diagnosis of cancer is often a shocking and emotionally challenging experience. It can have a profound impact on individuals, both …

Read On »

Blood Clots

Why Are Blood Clots Dangerous?

Blood clotting is a vital survival mechanism. When we experience injuries like cuts or scrapes, our body employs a complex and organized process to prevent excessive bleeding. Here’s how it works: Platelet Response: Damaged tissues send signals into the bloodstream, prompting platelets to rush to the injury site. These platelets start plugging the wound. Coagulation …

Read On »

Breast cancer awarness month

Understanding Breast Cancer Risk Factors: What You Need to Know

Breast cancer, a formidable adversary, affects millions of lives worldwide each year. In our quest to combat this disease, knowledge is the most potent weapon we have. Breast Cancer Awareness Month is the ideal time to explore the intricacies of breast cancer risk factors, from the genetic underpinnings to lifestyle choices that can influence your …

Read On »

oncology

A Guide to Understanding Inpatient Medical Oncology: 10 Points to Consider

I just spent a very busy month on the inpatient medical oncology service and thought I would share some insight about what medical oncologist see and do in-house.   Navigating the healthcare system can often feel like a maze, particularly when a loved one is admitted to the hospital and under the care of multiple specialists. …

Read On »

Myeloproliferative Disorders

Myeloproliferative Disorders

Myeloproliferative disorders are a group of conditions characterized by overactivity in the bone marrow. Many of these conditions are driven by mutations in the JAK-2 gene (Janus Kinase 2 gene), which plays a crucial role in regulating the growth and production of cells in the bone marrow. While there are other mutations involved, JAK-2 mutations …

Read On »

Advancements in Hodgkin's Lymphoma

Advancements in Hodgkin’s Lymphoma

Traditional Treatment Approaches for Hodgkin’s Lymphoma Lymphomas encompass a diverse group of blood cancers, with various types and treatment approaches depending on factors such as lymphoma subtype, origin, and aggressiveness. One particular lymphoma subtype with unique treatment options is Hodgkin’s lymphoma. Traditionally, in the United States, Hodgkin’s lymphoma has been treated with a chemotherapy combination …

Read On »

CAR-T and Bispecific Antibodies ii

CAR-T and Bispecific Antibodies-By Dr Landau

We are currently in an era where we’re shifting from traditional chemotherapies to leveraging the body’s immune system. CAR-T and bispecific antibodies are two innovative approaches to achieve this.

Grading Drug Toxicities

Grading Drug Toxicities

In the realm of oncology trials, we employ a severity rating system known as the Grade scale to assess toxicities. This scale helps us gauge whether a patient should modify or discontinue their treatment. The Grade scale consists of five points, ranging from mild toxicities to life-threatening ones.

Uveal melanoma, a rare and aggressive form of eye cancer, has just witnessed a groundbreaking development in its treatment landscape. The Food and Drug Administration (FDA) recently granted approval to the HEPZATO KIT, an innovative liver-directed therapy that offers new hope to adult patients with uveal melanoma and unresectable hepatic metastases.

A Breakthrough in Uveal Melanoma Treatment: HEPZATO KIT

Uveal melanoma, a rare and aggressive form of eye cancer, has just witnessed a groundbreaking development in its treatment landscape. The Food and Drug Administration (FDA) recently granted approval to the HEPZATO KIT, an innovative liver-directed therapy that offers new hope to adult patients with uveal melanoma and unresectable hepatic metastases.

  • Previous
  • Page 1
  • …
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • …
  • Page 28
  • Next

Recent Posts

  • When the System Works: A TIL Therapy Story
  • The Next Generation of TIL Therapy Has Arrived — And It Skips the IL-2
  • A Third Chance for RP1: An Option Melanoma Patients Still Need
  • The BRAF Pathway to TIL Program: Why Earlier Planning May Change the Treatment Journey for Melanoma Patients
  • The TIL Journey: From a Medical Oncologist’s Perspective

Categories

  • Art of Oncology (99)
  • Current News (17)
  • Immunotherapy News (13)
  • Navigation Corner (6)
  • Prevention and Healthy Lifestyle (18)
  • Reflections (3)
  • Research Advances (121)
    • Clinical Trials (52)
    • Immunotherapy (33)
    • New Treatments and Therapies (44)
  • The essentials (41)
    • Radiology (4)
  • Travel Health (1)
  • Uncategorized (10)
  • Varied Cancer Perspectives (127)
    • Biliary tract cancer (3)
    • Bladder Cancer (3)
    • Breast Cancer (10)
    • Cervical Cancer (2)
    • CNS Cancers (1)
    • Colorectal cancer (15)
    • Esophageal Cancer (2)
    • Gastric cancer (6)
    • Hepatic Tumors (1)
    • Leiomyosarcoma (2)
    • Leukemia (3)
    • Lung Cancer (11)
    • Lymphoma (3)
    • Melanoma (35)
    • Multiple Myeloma (3)
    • Neuroendocrine cancer (2)
    • Ovarian Cancer (3)
    • Pancreatic Cancer (5)
    • Prostate Cancer (5)
    • Sarcoma (2)
    • Sickle Cell Disease (4)
    • Skin Cancer (9)
    • Thyroid cancer (1)
    • Urothelial Cancer (1)
  • Video (2)
  • Weekly Newsletter (6)

Get in touch!

  • Facebook
  • Instagram
  • TikTok
  • LinkedIn


Meet the authors

Dr. Sajeve Thomas
Dr Daniel Landau


Subscribe


  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts
© 2026 MedOncMD. Minimal Theme by SPYR
✕
  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts